14.29
-0.03
(-0.21%)
At close: January 30 at 4:00:01 PM EST
14.22
-0.07
(-0.49%)
After hours: 7:26:33 PM EST
Key Executives
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Richard Lowenthal M.B.A., M.S., MSMSEL | Founder, President, CEO & Director | 2.75M | -- | 1966 |
| Dr. Sarina Tanimoto M.B.A., M.D. | Co-Founder & Chief Medical Officer | 2.47M | -- | 1969 |
| Mr. Alexander A. Fitzpatrick Esq. | Chief Legal Officer & Secretary | 677.14k | -- | 1967 |
| Dr. Robert Bell Ph.D. | Co-Founder & Chief Science Officer | -- | -- | -- |
| Ms. Kathleen D. Scott CPA | Chief Financial Officer | -- | -- | -- |
| Mr. Brian T. Dorsey M.S. | Chief Operations Officer | -- | -- | 1969 |
| Mr. Daniel Relovsky | Senior Vice President of Marketing | -- | -- | -- |
| Mr. Harris Kaplan M.B.A. | Executive Vice President of Commercial Strategy | -- | -- | 1952 |
| Mr. Eric Karas | Chief Commercial Officer | 618.61k | -- | 1973 |
| Mr. Justin Chakma | Chief Business Officer & Secretary | -- | -- | 1989 |
ARS Pharmaceuticals, Inc.
11682 El Camino Real
Suite 120
San Diego, CA 92130
United States
- Sector:
- Healthcare
- Industry: Biotechnology
- Full Time Employees:
- 24
Description
ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.
Corporate Governance
ARS Pharmaceuticals, Inc.’s ISS Governance QualityScore as of January 1, 2025 is 10. The pillar scores are Audit: 9; Board: 10; Shareholder Rights: 8; Compensation: 9.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
March 19, 2025 at 10:59 AM UTC - March 24, 2025 at 12:00 PM UTC
ARS Pharmaceuticals, Inc. Earnings Date
Recent Events
November 18, 2024 at 12:00 AM UTC
CORRESP: A correspondence can be sent as a document with another submission type or can be sent as a separate submission
Related Tickers
VRNA Verona Pharma plc
57.24
+4.40%
MIST Milestone Pharmaceuticals Inc.
2.0200
+1.00%
TVTX Travere Therapeutics, Inc.
21.05
+2.93%
AXSM Axsome Therapeutics, Inc.
108.85
+3.53%
ARQT Arcutis Biotherapeutics, Inc.
13.67
-0.36%
TARS Tarsus Pharmaceuticals, Inc.
51.74
-2.51%
BBIO BridgeBio Pharma, Inc.
35.97
-1.34%
MDGL Madrigal Pharmaceuticals, Inc.
338.29
+3.66%
CYTK Cytokinetics, Incorporated
49.97
+2.71%
HRMY Harmony Biosciences Holdings, Inc.
39.54
+1.85%